Investigating how cadmium exposure affects Alzheimer's disease genes using brain organoids

Examining the effect of cadmium metal exposure on Alzheimer's disease genetic alleles using herpes viral infected cerebral organoids

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10973830

This study is looking at how exposure to cadmium, a harmful metal, and herpes virus might affect genes related to Alzheimer's disease, using tiny brain models made from human cells, to help us understand how these factors could influence the development of the disease.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10973830 on NIH RePORTER

What this research studies

This research explores the impact of cadmium, a heavy metal, on genetic factors associated with Alzheimer's disease (AD) by utilizing human brain organoids. The study aims to understand how cadmium exposure, both alone and in combination with herpes virus infection, influences the expression of AD-related biomarkers. By analyzing these effects in a controlled laboratory setting, researchers hope to uncover the mechanisms linking environmental toxins and viral infections to Alzheimer's pathology. This could provide insights into how genetic variations may modify these effects.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a genetic predisposition to Alzheimer's disease or those concerned about environmental exposures related to cognitive decline.

Not a fit: Patients who do not have a genetic risk for Alzheimer's disease or are not exposed to cadmium may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by identifying environmental risk factors and their interactions with genetic predispositions.

How similar studies have performed: Previous research has shown promising results in understanding the links between heavy metal exposure and Alzheimer's disease, but this specific approach using cerebral organoids is relatively novel.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.